首页123456下页尾页 共 213 条记录, 当前第1/11页。
A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes
2012/10/10 12:00
Condition:   Diabetes Mellitus Non Insulin Dependent Oral Agent Therapy
Interventions:   Drug: BRL 49653C;   Drug: Placebo
Sponsors:   National Taiwan University Hospital;   National Taiwan University Hospital
Completed - verified September 2012
Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery Disease
2012/4/4 12:00
Conditions:   Prediabetes;   Coronary Artery Disease;   Insulin Resistance;   Glucose Intolerance
Interventions:   Drug: placebo tablet;   Drug: rosiglitazone (4 mg)/day
Sponsors:   National Cheng-Kung University Hospital;   National Cheng-Kung University Hospital
Completed - verified April 2012
Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy
2012/3/27 12:00
Condition:   Type 2 Diabetes Mellitus With Features of Insulin Resistance
Interventions:   Other: EA + Rosiglitazone;   Drug: TZD
Sponsors:   China Medical University Hospital;   China Medical University Hospital
Completed - verified April 2012
A 24 Weeks, Randomized, Double-blind Trial Compares the Efficacy and Safety of Fixed-dose Rosiglitazone/Glimepiride Therapy to Glimepiride Monotherapy in China Drug Naive T2DM patientsAVY
2011/10/13 12:00
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: rosiglitazone/glimepiride fix dose combination;   Drug: glimepiride
Sponsor:   GlaxoSmithKline
Terminated - verified August 2011
Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH
2011/7/27 12:00
Condition:   NASH (Non-alcoholic Steato-hepatitis)
Interventions:   Drug: Rosiglitazone;   Drug: alpha-lipoic acid;   Drug: Rosiglitazone/alpha-lipoic acid
Sponsors:   Seoul St. Mary's Hospital;   GlaxoSmithKline
Suspended - verified January 2004
A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects
2011/7/19 12:00
Condition:   Healthy Volunteers
Interventions:   Drug: Tasimelteon;   Drug: Rosiglitazone;   Drug: Midazolam
Sponsor:   Vanda Pharmaceuticals
Not yet recruiting - verified July 2011
Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects
2011/6/16 12:00
Condition:   Healthy Adult Subjects
Intervention:   Drug: FG-4592
Sponsor:   FibroGen
Completed - verified June 2011
Precription Patterns, Resource Utilization and Cost Associated With add-on Therapy With Anti Dipeptidyl Peptidase-IVs Versus Rosiglitazone
2011/4/7 12:00
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Rosiglitazone + Metformin;   Drug: Sitagliptin + Metformin
Sponsor:   GlaxoSmithKline
Completed - verified April 2011
An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010
2011/2/10 12:00
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Administration of rosiglitazone/metformin
Sponsor:   GlaxoSmithKline
Completed - verified February 2011
BAY73-4506 Probe Substrate Study
2011/1/31 12:00
Condition:   Neoplasms
Interventions:   Drug: Regorafenib (BAY73-4506) + warfarin + omeprazole + midazolam;   Drug: Regorafenib (BAY73-4506) + rosiglitazone
Sponsor:   Bayer
Not yet recruiting - verified May 2011
A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists
2010/9/23 12:00
Condition:   Solid Cancers
Interventions:   Drug: GDC-0449;   Drug: oral contraceptive;   Drug: rosiglitazone
Sponsor:   Genentech
Recruiting - verified February 2011
Malignancy Meta Analysis for BRL49653
2010/9/1 12:00
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: allocation of treatment with metformin or rosiglitazone
Sponsor:   GlaxoSmithKline
Completed - verified September 2010
Avandamet Bioequivalence Study Brazil - Fed Administration
2010/8/31 12:00
Conditions:   Healthy Volunteers;   Diabetes Mellitus, Type 2
Interventions:   Drug: Rosiglitazone Maleate + Metformin 2 miligrams (mg) + 500 mg;   Drug: Rosiglitazone Maleate + Metformin 4 miligrams (mg) + 1000 mg
Sponsor:   GlaxoSmithKline
Completed - verified April 2011
Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging
2010/7/30 12:00
Condition:   Pneumonia
Interventions:   Drug: Rosiglitazone;   Drug: Zileuton;   Drug: Rosiglitazone placebo;   Drug: Zileuton placebo
Sponsors:   Washington University School of Medicine;   Doris Duke Charitable Foundation
Not yet recruiting - verified March 2011
Effects of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
2010/6/18 12:00
Conditions:   Diabetes Mellitus, Type 2;   Newly Diagnosed
Interventions:   Drug: exenatide injection;   Drug: Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R;   Drug: Pioglitazone
Sponsors:   Sun Yat-sen University;   Ministry of Health, China;   Eli Lilly and Company
Recruiting - verified October 2010
Effect of Rosiglitazone on the Vascular Biology of Human Fat Tissue
2010/6/17 12:00
Conditions:   Metabolic Syndrome;   Insulin Resistance
Interventions:   Drug: Rosiglitazone;   Drug: Placebo
Sponsors:   University of Massachusetts, Worcester;   GlaxoSmithKline
Completed - verified June 2010
A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
2010/3/22 12:00
Conditions:   Papillary Thyroid Cancer;   Follicular Thyroid Cancer;   Huerthle Cell Thyroid Cancer;   Renal Cell Carcinoma
Interventions:   Drug: rosiglitazone;   Drug: XL184
Sponsor:   Exelixis
Active, not recruiting - verified June 2011
A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers
2010/2/26 12:00
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: pioglitazone/rosiglitazone/placebo;   Drug: rosiglitazone/pioglitazone/placebo;   Drug: placebo/pioglitazone/rosiglitazone;   Drug: pioglitazone/placebo/rosiglitazone;   Drug: rosiglitazone/placebo/pioglitazone;   Drug: placebo/rosiglitazone/pioglitazone
Sponsor:   Solvay Pharmaceuticals
Completed - verified March 2010
Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770
2010/1/29 12:00
Condition:   Cystic Fibrosis
Interventions:   Drug: VX-770;   Drug: VX-770
Sponsor:   Vertex Pharmaceuticals Incorporated
Completed - verified April 2010
Fracture Risk With Thiazolidinediones
2010/1/21 12:00
Conditions:   Fractures, Bone;   Type II Diabetes
Interventions:   Drug: TZD only (RSG or PIO or troglitazone);   Drug: TZD + spironolactone;   Drug: TZD + amiloride
Sponsor:   GlaxoSmithKline
Completed - verified June 2011